Two decades of SVT ablation in Denmark: a trend towards higher age, more comorbidity, and less prior use of antiarrhythmic and rate-limiting pharmacotherapy-a nationwide registry-based Danish study.
Charlotte MiddelfartJacob TønnesenChristopher R ZörnerLise Da Riis-VestergaardMaria Hang Xuan PhamJannik Langtved PallisgaardMartin H RuwaldPeter Vibe RasmussenArne JohannessenJim HansenRene WorckGunnar GislasonMorten Lock HansenPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2023)
Between 2001 and 2018, CA was increasingly performed in patients with SVT, primarily AVNRT- and EAT patients. The burden of comorbidities increased. Patients undergoing CA without prior antiarrhythmic- or rate-limiting drug therapy increased significantly. Use of beta-blockers increased and remained the most widely used drug.